Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study (years) |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | N-acetylaspartic acid | 198 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 385 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 458 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 468 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 534 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 693 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 696 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 702 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 928 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 7 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 937 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 1268 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 1375 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 1460 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 1562 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 1793 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 2049 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 2252 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 7 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 2492 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 10 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 2545 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 2758 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 10 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 2831 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 10 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 2846 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 3350 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 7 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 3851 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 3958 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 4054 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 4070 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 4071 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 7 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 4156 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 4279 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 4386 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 4411 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 4593 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 4645 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 4826 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 5086 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 5725 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 6148 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 6357 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 6622 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 6802 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 6825 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 6902 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 6970 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 7001 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 7041 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 7386 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | N-acetylaspartic acid | 7844 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 8944 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 9096 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 10046 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 12685 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 16165 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
GC POSITIVE ION MODE | N-acetylaspartic acid | 17287 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |